Literature DB >> 23760276

Structural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.

Timothy F Fernandez1, Alexandra B Samal, Gregory J Bedwell, Yabing Chen, Jamil S Saad.   

Abstract

The extrinsic apoptotic pathway is initiated by cell surface death receptors such as Fas. Engagement of Fas by Fas ligand triggers a conformational change that allows Fas to interact with adaptor protein Fas-associated death domain (FADD) via the death domain, which recruits downstream signaling proteins to form the death-inducing signaling complex (DISC). Previous studies have shown that calmodulin (CaM) is recruited into the DISC in cholangiocarcinoma cells, suggesting a novel role of CaM in Fas-mediated signaling. CaM antagonists induce apoptosis through a Fas-related mechanism in cholangiocarcinoma and other cancer cell lines possibly by inhibiting Fas-CaM interactions. The structural determinants of Fas-CaM interaction and the underlying molecular mechanisms of inhibition, however, are unknown. Here we employed NMR and biophysical techniques to elucidate these mechanisms. Our data show that CaM binds to the death domain of Fas (FasDD) with an apparent dissociation constant (Kd) of ~2 μM and 2:1 CaM:FasDD stoichiometry. The interactions between FasDD and CaM are endothermic and entropically driven, suggesting that hydrophobic contacts are critical for binding. We also show that both the N- and C-terminal lobes of CaM are important for binding. NMR and surface plasmon resonance data show that three CaM antagonists (N-(6-aminohexyl)-5-chloro-1-naphthalene sulfonamide, tamoxifen, and trifluoperazine) greatly inhibit Fas-CaM interactions by blocking the Fas-binding site on CaM. Our findings provide the first structural evidence for Fas-CaM interactions and mechanism of inhibition and provide new insight into the molecular basis for a novel role of CaM in regulating Fas-mediated apoptosis.

Entities:  

Keywords:  Apoptosis; Calmodulin; Cholangiocarcinoma; Fas; NMR; Surface Plasmon Resonance (SPR)

Mesh:

Substances:

Year:  2013        PMID: 23760276      PMCID: PMC3724645          DOI: 10.1074/jbc.M113.471821

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

Review 1.  The death receptors.

Authors:  M E Peter; C Scaffidi; J P Medema; F Kischkel; P H Krammer
Journal:  Results Probl Cell Differ       Date:  1999

2.  FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.

Authors:  A M Chinnaiyan; K O'Rourke; M Tewari; V M Dixit
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

3.  Frequent mutations of Fas gene in thyroid lymphoma.

Authors:  T Takakuwa; Z Dong; H Takayama; F Matsuzuka; S Nagata; K Aozasa
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

4.  Allosteric effects of the antipsychotic drug trifluoperazine on the energetics of calcium binding by calmodulin.

Authors:  Michael D Feldkamp; Susan E O'Donnell; Liping Yu; Madeline A Shea
Journal:  Proteins       Date:  2010-08-01

Review 5.  The kiss of death: promises and failures of death receptors and ligands in cancer therapy.

Authors:  P T Daniel; T Wieder; I Sturm; K Schulze-Osthoff
Journal:  Leukemia       Date:  2001-07       Impact factor: 11.528

6.  Conformation and structural transitions in the EF-hands of calmodulin.

Authors:  A K Moorthy; M R Murthy
Journal:  J Biomol Struct Dyn       Date:  2001-08

7.  Drug binding by calmodulin: crystal structure of a calmodulin-trifluoperazine complex.

Authors:  W J Cook; L J Walter; M R Walter
Journal:  Biochemistry       Date:  1994-12-27       Impact factor: 3.162

8.  Simultaneous binding of drugs with different chemical structures to Ca2+-calmodulin: crystallographic and spectroscopic studies.

Authors:  B G Vertessy; V Harmat; Z Böcskei; G Náray-Szabó; F Orosz; J Ovádi
Journal:  Biochemistry       Date:  1998-11-03       Impact factor: 3.162

9.  Calmodulin binding to cellular FLICE-like inhibitory protein modulates Fas-induced signalling.

Authors:  Pritish S Pawar; Keith J Micoli; Haitao Ding; William J Cook; John C Kappes; Yabing Chen; Jay M McDonald
Journal:  Biochem J       Date:  2008-06-15       Impact factor: 3.857

10.  Biophysical and cell-based evidence for differential interactions between the death domains of CD95/Fas and FADD.

Authors:  B J Ferguson; D Esposito; J Jovanović; A Sankar; P C Driscoll; H Mehmet
Journal:  Cell Death Differ       Date:  2007-06-29       Impact factor: 15.828

View more
  8 in total

Review 1.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

2.  Structural and Biophysical Characterization of the Interactions between Calmodulin and the Pleckstrin Homology Domain of Akt.

Authors:  Constance Agamasu; Ruba H Ghanam; Jamil S Saad
Journal:  J Biol Chem       Date:  2015-09-21       Impact factor: 5.157

3.  The Interplay between Calmodulin and Membrane Interactions with the Pleckstrin Homology Domain of Akt.

Authors:  Constance Agamasu; Ruba H Ghanam; Fei Xu; Yong Sun; Yabing Chen; Jamil S Saad
Journal:  J Biol Chem       Date:  2016-11-21       Impact factor: 5.157

4.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Authors:  Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

Review 5.  Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.

Authors:  Massimiliano Cadamuro; Simone Brivio; Carlo Spirli; Ruth E Joplin; Mario Strazzabosco; Luca Fabris
Journal:  Int J Mol Sci       Date:  2017-01-13       Impact factor: 5.923

6.  KRAS Prenylation Is Required for Bivalent Binding with Calmodulin in a Nucleotide-Independent Manner.

Authors:  Constance Agamasu; Rodolfo Ghirlando; Troy Taylor; Simon Messing; Timothy H Tran; Lakshman Bindu; Marco Tonelli; Dwight V Nissley; Frank McCormick; Andrew G Stephen
Journal:  Biophys J       Date:  2019-02-15       Impact factor: 4.033

7.  N-terminal and C-terminal domains of calmodulin mediate FADD and TRADD interaction.

Authors:  Giuliana Papoff; Nadia Trivieri; Sonia Marsilio; Roberta Crielesi; Cristiana Lalli; Loriana Castellani; Edward M Balog; Giovina Ruberti
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

8.  Identification of the Calmodulin-Binding Domains of Fas Death Receptor.

Authors:  Bliss J Chang; Alexandra B Samal; Jiri Vlach; Timothy F Fernandez; Dewey Brooke; Peter E Prevelige; Jamil S Saad
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.